Zydus Lifesciences (ZYDUSLIF IN): Q1FY25 PAT Jumps 31%; Increasing Focus on US To Augur Well
Zydus Lifesciences reports stellar Q1FY25 performance with highest ever operating profit and margin, driven by the US and India. The company...
364 Views
Indian Pharmaceutical Market: On A Healthy Growth Path; Momentum to Continue in Rest of the Year
Indian pharmaceutical market grew 8.7% in Q1FY25. Most of the top players reported double-digit revenue growth in domestic market. Nifty Pharma...
425 Views
Akums Drugs and Pharmaceuticals IPO Trading - Strong Demand and a Decent Margin of Safety
Akums Drugs and Pharmaceuticals (0200361D IN) raised around US$222m in its India IPO, after pricing the deal at the top end of the range at INR679...
350 Views
Mankind Pharma: Bharat Serum Acquisition to Be EPS Accretive from FY28
Mankind Pharma (Mankind) has entered into a definitive agreement to acquire a 100% stake in Bharat Serum and Vaccines (BSV) from Advent...
357 Views
Cipla (CIPLA IN): Starts FY25 On Firm Note; EBITDA Margin Ahead of Guidance Range
In Q1FY25, Cipla posted 7% YoY revenue growth to INR66.9B. EBITDA increased 26% YoY to INR17.2B, leading to 154bps margin expansion to 25.6%, ahead...
524 Views